Most ARMS tumors express a fusion transcription factor consisting of the DNA binding domain of a PAX family member (i.e., PAX3 or PAX7) and the transactivation domain of FOXO1 (i.e., PAX3-FOXO1 or PAX7-FOXO1)9. Here, FOXO1 is linked to alveolar rhabdomyosarcoma.